中国癌症杂志 ›› 2021, Vol. 31 ›› Issue (3): 212-220.doi: 10.19401/j.cnki.1007-3639.2021.03.008

• 论著 • 上一篇    下一篇

甲状腺未分化癌的预后因素分析及治疗决策

武元元 1 ,王 军 1 ,刘勤江 1 ,张 明 2   

  1. 1. 甘肃省肿瘤医院 / 甘肃省医学科学研究院头颈外科,甘肃 兰州 730050 ;
    2. 甘肃省肿瘤医院 / 甘肃省医学科学研究院放疗科,甘肃 兰州 730050
  • 出版日期:2021-03-30 发布日期:2021-04-01
  • 通信作者: 王 军 E-mail: Jack3376@126.com
  • 基金资助:
    甘肃省卫生行业科研计划项目(GSWSKY2018-05)。

Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma

WU Yuanyuan 1 , WANG Jun 1 , LIU Qinjiang 1 , ZHANG Ming #br#   

  1. 1. Department of Head and Neck Surgery, Gansu Provincial Cancer Hospital & Gansu Provincal Academic Institute for Medical Research, Lanzhou 730050, Gansu Province, China; 2. Department of Radiotherapy, Gansu Provincial Cancer Hospital & Gansu Provincal Academic Institute for Medical Research, Lanzhou 730050, Gansu Province, China
  • Published:2021-03-30 Online:2021-04-01
  • Contact: WANG Jun E-mail: Jack3376@126.com

摘要: 背景与目的:甲状腺未分化癌(anaplastic thyroid carcinoma,ATC)是一种临床罕见但侵袭性高的恶性肿瘤,预后极差,尚无标准的治疗方案。分析ATC的预后影响因素,探讨其合理的治疗方法。方法:回顾性分析2008年5月—2014年5月在甘肃省肿瘤医院接受诊治的37例ATC患者的社会人口学和临床病理学资料,采用Kaplan-Meier法计算生存率,采用log-rank检验进行比较,通过单因素和多因素COX模型分析筛选预后因素。结果:37例ATC患者中,男性12例,女性25例,年龄42~82岁,中位年龄为64岁;ATC占所有甲状腺癌的5.3%(37/698),29.7%(13/37)的患者合并甲状腺肿,居住在城市的患者不足20%(7/37),超过50%(19/37)的患者生活在地方性甲状腺肿高发地区;全组患者平均生存期为11.5个月,中位生存期为5.9个月,6个月、1年和2年的生存率分别为48.6%、21.6%和13.5%。单因素分析显示,首诊年龄、合并甲状腺肿、远处转移、手术、综合治疗、术后放疗和白细胞计数是影响ATC患者生存的预后因素。多因素分析显示,首诊年龄≤50岁(HR=0.21,95% CI:0.06~0.77,P=0.019)、手术(HR=0.15,95% CI:0.04~0.59,P=0.007)和综合治疗(HR=0.31,95% CI:0.11~0.85,P=0.023)是预后较好的独立预测因素。对于手术患者,R2切除(HR=7.98,95% CI:1.38~46.21,P=0.020)和远处转移(HR=6.26,95% CI:1.65~23.83,P=0.007)是预后不良的独立风险因素,术后放疗(HR=0.18,95% CI:0.04~0.83,P=0.028)可明显改善预后。结论:年龄、手术切除方式、手术+术后放疗是影响ATC生存的独立预测因素,根据患者的个体情况进行以手术+术后放疗为主的综合治疗可能改善其生存。

关键词: 甲状腺未分化癌, 预后, 因素分析, 生存, 治疗方法

Abstract: Background and purpose: Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive malignancy with poor prognosis, and there is no standardized therapeutic regimen. The aim of the study was to analyze the prognostic factors influencing survival of the patients with ATC, and to explore the reasonable treatment methods. Methods: The sociodemographic and clinicopathologic characteristics of 37 ATC patients at the Department of Head and Neck Surgery in Gansu Provincial Cancer Hospital between May 2008 and May 2014 were analyzed retrospectively. The Kaplan-Meier method and log-rank test were used to determine and compare the survival. Potential prognostic factors were identified by univariate and multivariate Cox regression analyses. Results: Females were more affected. Twenty-five cases occurred in women, and 12 in males. The age range was 42-82 years, and the median age was 64. ATC accounted for 5.3% of all thyroid cancers in this study, and goiter was present in 29.7% of patients with ATC. Less than 20% of the ATC patients lived in urban areas, and more than half lived in endemic goiter areas. Mean survival time was 11.5 months. Median survival time was 5.9 months, and half-, 1- and 2-year overall survival rates were 48.6%, 21.6% and 13.5%, respectively. Univariate analysis showed that age, goiter, distant metastasis, surgery, comprehensive therapy and postoperative radiotherapy were independent prognostic factors of survival in all ATC patients. Multivariate analysis showed that age no more than 50 years (HR=0.21, 95% CI: 0.06-0.77, P=0.019), surgery (HR=0.15, 95% CI: 0.04-0.59, P=0.007) and comprehensive therapy (HR=0.31, 95% CI: 0.11-0.85, P=0.023) were independent protective factors associated with the survival of ATC patients. With regard to operated patients,macroscopic residual tumor (HR=7.98, 95% CI: 1.38-46.21, P=0.020) and distant metastasis (HR=6.26, 95% CI: 1.65-23.83, P=0.007) were independent risk factors of survival. Postoperative radiotherapy (HR=0.18, 95% CI: 0.04-0.83, P=0.028) was a protective factor. Conclusion: Age, type of surgery resection and postoperative radiotherapy influence prognosis of ATC independently. The patients with ATC may have a better prognosis by receiving multidisciplinary comprehensive therapy combining surgery and postoperative radiotherapy with or without chemotherapy based on each individual circumstance.

Key words: Anaplastic thyroid cancer, Prognosis, Factor analysis, Survival, Treat methods